A federal judge allowed a Georgia law banning hormonal interventions for transgender youth to take effect earlier this week, in order to comply with a federal court ruling last month.
On August 21, a three-judge panel of the 11th U.S. Circuit Court of Appeals vacated a lower court’s injunction blocking state authorities from enforcing a similar law in Alabama.
In a decision criticized by LGBTQ advocates, Circuit Judge Barbara Lagoa, a Trump appointee, ruled that the district court had applied the wrong standard when determining whether to issue an injunction blocking the law.
Lagoa argued that there is no constitutional right of parents to “treat [one’s] children with transitioning medications subject to medically accepted standards,” as argued by plaintiffs.
This comes even though the Supreme Court, in numerous other legal battles, has ruled parents possess a fundamental right to raise their children as they see fit.
As a result of Lagoa’s opinion, the Alabama law was allowed to go into effect. State authorities can punish doctors who prescribe gender-affirming treatments to minors suffering from gender dysphoria.
Given the 11th Circuit’s jurisdiction over Georgia, it was only a matter of time before the courts allowed authorities in the Peach State to enforce a nearly identical law — which technically went into effect on July 1 — barring those under age 18 from accessing gender-affirming treatments.
On September 5, U.S. District Judge Sarah Geraghty, of the Northern District of Georgia, issued an order pausing an injunction she issued on the day prior to the 11th Circuit’s decision.
In issuing that initial injunction, Geraghty found that a group of four transgender plaintiffs and their parents would suffer “irreparable harm” if the law were not halted while its constitutionality is debated in the courts.
Following the 11th Circuit’s decision, Geraghty paused the injunction, but refused — despite the protestations of proponents of the law — to completely vacate the injunction, reports The Hill.
As a result, Georgia can now discipline and potentially pull the medical licenses of practitioners who prescribe gender-affirming treatments to minors, including surgical and hormonal interventions.
Georgia’s law does contain a limited exception for youth who have already started hormone therapy by allowing them to continue their course of treatment, but bars new patients from accessing those same treatments.
And, hypocritically, Georgia’s law — which echoes similar legislation passed in 21 other states — also permits doctors to prescribe hormonal treatments and perform surgeries on intersex youth in order to “force” their bodies to conform to a binary gender expression or appearance.
In July, the 6th Circuit Court of Appeals allowed a ban on gender-affirming care in Tennessee to take effect, ruling that a lower court judge applied the wrong legal standard in issuing an injunction blocking the law. That ruling was subsequently applied to overturn an injunction blocking a similar Kentucky law from being enforced.
U.S. Rep. Becca Balint has introduced a bill to protect and expand access to gender-affirming care for transgender individuals at a time when the Trump administration is seeking to restrict the practice.
The Vermont Democrat's bill -- the Transgender Health Care Access Act -- establishes grants to support medical education programs and professional training in transition-related care, and to expand access to such services in rural communities.
She introduced the bill on March 31, coinciding with Transgender Day of Visibility.
The congresswoman noted in a news release that in a survey of students at 10 medical schools, nearly 4 in 5 students did not feel competent at treating transgender patients suffering from gender dysphoria.
The Trump administration has ordered the U.S. National Institutes of Health (NIH) to study the physical and mental health effects of transitioning, both socially and medically.
In an internal NIH memo obtained by National Public Radio, Acting NIH Director Mark Memoli declared that the agency should study the impact of "social transition and/or chemical and surgical mutilation" among trans-identifying children.
Specifically, the White House wants the NIH to study "regret" and rates of so-called "detransition" among children and adults who have previously transitioned.
The Republican Senate Leadership Fund is spending over a million dollars to air an ad attacking Sen. Jon Osssoff (D-Ga.) over the issue of transgender participation in sports.
The conservative super PAC's ad highlights the senator's opposition to the "Fair and Safe Athletic Opportunities Act," a congressional bill seeking to enshrine into law a ban that would prohibit transgender athletes from competing on female-designated sports teams.
The bill sought to amend Title IX, a federal law prohibiting sex discrimination in government-funded schools, to explicitly prohibit schools from allowing transgender women and girls to compete as females.
These are challenging times for news organizations. And yet it’s crucial we stay active and provide vital resources and information to both our local readers and the world. So won’t you please take a moment and consider supporting Metro Weekly with a membership? For as little as $5 a month, you can help ensure Metro Weekly magazine and MetroWeekly.com remain free, viable resources as we provide the best, most diverse, culturally-resonant LGBTQ coverage in both the D.C. region and around the world. Memberships come with exclusive perks and discounts, your own personal digital delivery of each week’s magazine (and an archive), access to our Member's Lounge when it launches this fall, and exclusive members-only items like Metro Weekly Membership Mugs and Tote Bags! Check out all our membership levels here and please join us today!
You must be logged in to post a comment.